Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Malformations of Cortical Development, Group II

ClinicalTrials.gov lists 8 trials for Malformations of Cortical Development, Group II or a narrower condition beneath it.

MeSH D054081 Nervous System Diseases C10 C16
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Not applicable Not applicable 2 Observational Observational 6 Not applicable Not applicable 2 Observational Observational 6

Trials per phase

1 of the 8 trials are tagged with Malformations of Cortical Development, Group II itself; the rest are tagged with a narrower condition beneath it.

Get the Malformations of Cortical Development, Group II report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Malformations of Cortical Development, Group II trials start? (7)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Not applicable
  • Observational

Top of scale: 2

1996: 1 trials (Observational 1) 2006: 1 trials (Observational 1) 2007: 1 trials (Observational 1) 2009: 1 trials (Observational 1) 2013: 1 trials (Observational 1) 2022: 1 trials (Not applicable 1) 2023: 2 trials (Observational 1, Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2023 2
2022 1
2013 1
2009 1
2007 1
2006 1
1996 1

No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Malformations of Cortical Development, Group II trials in? (2)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Not applicable 2
Observational 6

How many Malformations of Cortical Development, Group II trials are recruiting? (3)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 4
Completed 1
Unknown status 3

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Sub-conditions in MeSH (4)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, publications, prevalence, and rare-disease identity.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages